Prostacyclin in human non-small cell lung cancers.
Nana-Sinkam
Patrick
P
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. patrick.nana-sinkam@uchsc.edu
Golpon
Heiko
H
Keith
Robert L
RL
Oyer
Ryan J
RJ
Sotto-Santiago
Sylk
S
Moore
Mark D
MD
Franklin
Wilbur
W
Nemenoff
Raphael A
RA
Geraci
Mark W
MW
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism*; D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000201:enzymology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D015232:Dinoprostone / Q000378:metabolism*; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000378:metabolism*; D008175:Lung Neoplasms / Q000201:enzymology*; D009363:Neoplasm Proteins / Q000378:metabolism*
D009363:Neoplasm Proteins; D015121:6-Ketoprostaglandin F1 alpha; D003577:Cytochrome P-450 Enzyme System; D011464:Epoprostenol; D019746:Intramolecular Oxidoreductases; C022461:prostacyclin synthetase; D015232:Dinoprostone